Belite Bio, Inc (BLTE)

Belite Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	-	88.16	42.09	17.34	25.62
Cash & Short-Term Investments	-	88.16	42.09	17.34	25.62
Cash Growth	-	109.45%	142.67%	-32.30%	-
Other Receivables	-	0.84	0	-	-
Receivables	-	0.84	0	-	-
Prepaid Expenses	-	0.92	0.7	0.06	0.01
Other Current Assets	113.86	0.03	0.02	0.02	0.04
Total Current Assets	113.86	89.94	42.81	17.43	25.67
Property, Plant & Equipment	-	1.3	1.35	0.09	0.05
Long-Term Deferred Charges	-	-	-	0.82	-
Other Long-Term Assets	4.57	3.4	0.12	0.01	0.03
Total Assets	118.43	94.64	44.27	18.35	25.74
Accrued Expenses	-	3.18	1.83	1.54	0.97
Current Portion of Leases	-	0.31	0.2	-	-
Other Current Liabilities	3.84	0.15	0.07	0.1	0.01
Total Current Liabilities	3.84	3.63	2.1	1.64	0.97
Long-Term Leases	-	0.58	0.67	-	-
Total Liabilities	3.84	4.21	2.77	1.64	0.97
Common Stock	114.59	0	0	0	0
Additional Paid-In Capital	-	162.31	81.76	12.33	10.56
Retained Earnings	-	-71.5	-39.87	-27.22	-17.56
Comprehensive Income & Other	-	-0.37	-0.39	-0.2	-0.04
Total Common Equity	114.59	90.43	41.5	-15.09	-7.04
Shareholders' Equity	114.59	90.43	41.5	16.71	24.77
Total Liabilities & Equity	118.43	94.64	44.27	18.35	25.74
Total Debt	-	0.89	0.87	-	-
Net Cash (Debt)	-	87.27	41.22	17.34	25.62
Net Cash Growth	-	111.70%	137.68%	-32.30%	-
Net Cash Per Share	-	3.28	2.06	1.81	2.91
Filing Date Shares Outstanding	30.61	29.15	24.9	10.27	9.57
Total Common Shares Outstanding	30.61	29.15	24.9	10.27	9.57
Working Capital	110.02	86.31	40.7	15.8	24.7
Book Value Per Share	3.74	3.10	1.67	-1.47	-0.74
Tangible Book Value	114.59	90.43	41.5	-15.09	-7.04
Tangible Book Value Per Share	3.74	3.10	1.67	-1.47	-0.74
Machinery	-	0.49	0.45	0.14	0.09
Leasehold Improvements	-	0.19	0.19	-	-

Source: S&P Capital IQ. Standard template. Financial Sources.